The data presented by Jelinek et al. (1997) should not be taken as evidence against an association between resistance to sulphadoxine-pyrimethamine (S/P) and mutations in the dihydrofolate reductase gene of Plasmodium falciparum.

Benzer Materyaller

• Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
  Yazar:: Hastings, MD, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults.
  Yazar:: Fanello, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa.
  Yazar:: Ochong, E, ve diğerleri
  Baskı/Yayın Bilgisi: (2003)
• Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen
  Yazar:: Bamaga, O.A.A., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan
  Yazar:: Hamid, MMA, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)